Magnetic Resonance Imaging of HCC: Predictive Findings of Post-Transplant Tumor Recurrence in a Screening Population

Bobby Kalb¹, David Becker-Weidman², Surya Chundru¹, James Costello¹, Puneet Sharma¹, Khalil Salman¹, Hina Arif¹, Diego R. Martin¹

Reduction of post-transplant recurrence of hepatocellular carcinoma (HCC) is optimized by strict pre-transplant tumor staging (Milan criteria); however post-transplant tumor recurrence still occurs in up to 10% of patients with optimal preoperative staging. Imaging methodologies that are better able to predict recurrence risk of HCC from pretransplant imaging would be valuable in the triage of donor organs. Our study investigates potential imaging features on MRI that may provide added prognostic information regarding the biological behaviour of HCC, with the aim to better predict posttransplant recurrence.